Literature DB >> 26718066

Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization.

Alberto Palazzuoli1, Matteo Beltrami2, Gaetano Ruocco2, Beatrice Franci2, Maria Stella Campagna2, Ranuccio Nuti2.   

Abstract

BACKGROUND: The use of B-type natriuretic peptide (BNP) and echocardiography in acute heart failure (AHF) diagnosis is poorly employed in the Emergency Department. The aim of the present study is to evaluate relation among BNP levels systolic and diastolic dysfunction during early phases of AHF hospitalization.
METHODS: We performed contemporary echocardiographic and BNP assessment in 310 patients with AHF within 12h since hospital admission. We studied the correlation among BNP and degree of diastolic dysfunction evaluated by pulsed Doppler transmitral flow and Tissue Doppler flow. Finally we investigated the relation among BNP and the right systolic longitudinal ventricular function (TAPSE) and the systolic pulmonary arterial pressure (PAPs).
RESULTS: BNP levels were 1417±1126, 1081±955, 894±901pg/mL, for patients with EF≤25%, EF 25-40% and EF 40-50% (p=0.005), respectively. "BNP levels linearly correlate with the degree of diastolic dysfunction: 582±406pg/mL in altered relaxation pattern, 712±557pg/mL in pseudonormal pattern and 1694±805 in restrictive filling pattern (p<0.001 for all patterns)." BNP levels were significantly increased in patients with right systolic ventricular dysfunction (TAPSE<18mm; p=0.006) and in patients with PAPs≥40mmHg (p=0.001). ROC curve and logistic regression analysis highlighted the power of BNP to detect severe systolic dysfunction, right ventricular (RV) overload and dysfunction and diastolic dysfunction patterns.
CONCLUSIONS: BNP levels correlate linearly with LV systolic dysfunction as well as with impaired degree of diastolic dysfunction. Significant PAP increase is a further factor influencing BNP elevation in patients with AHF during early hospitalization phase.
Copyright © 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diastolic impairment; Echocardiography; Heart failure; Natriuretic peptides; Systolic dysfunction

Mesh:

Substances:

Year:  2015        PMID: 26718066     DOI: 10.1016/j.ejim.2015.11.031

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

1.  Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Matteo Beltrami; Ranuccio Nuti; John G Cleland
Journal:  Clin Res Cardiol       Date:  2018-03-12       Impact factor: 5.460

2.  Association of B-type natriuretic peptide with coronary plaque subtypes detected by coronary computed tomography angiography in patients with stable chest pain.

Authors:  Yuhai Yang; Caiqin Li; Lei Zhao
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-10       Impact factor: 2.357

3.  Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry.

Authors:  Elena Wolodimeroff; Pankaj Garg; Andrew J Swift; Graham Fent; Nigel Lewis; Dominic Rogers; Athanasios Charalampopoulos; Abdallah Al-Mohammad
Journal:  Open Heart       Date:  2022-06

Review 4.  Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload.

Authors:  Alberto Palazzuoli; Isabella Evangelista; Ranuccio Nuti
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.